The American Society of Health-System Pharmacists reports a shortage of injectable argotroban. This drug shortage is very important to people who can't take heparin. Sometimes heparin causes a reduction in the number of platelets in a person's blood to an unsafe level (thrombocytopenia). If this happens, the closely supervised use of argotroban can prevent blood clotting until the platelets return to a normal level. Then the dosage of another anticoagulant such as warfarin can be carefully adjusted while the argotroban dosage is decreased.
Showing posts with label heparin-induced thrombocytopenia. Show all posts
Showing posts with label heparin-induced thrombocytopenia. Show all posts
Monday, December 5, 2011
Subscribe to:
Posts (Atom)